Drug Patent Expirations in October 2014

Drug Patent Expirations for October 2014

Tradename Applicant Generic Name Patent Number Patent Expiration
DENAVIR Denco Asset penciclovir sodium 5,866,581 Oct 4, 2014
DENAVIR Denco Asset penciclovir sodium 6,124,304 Oct 4, 2014
REMODULIN United Therap treprostinil 5,153,222 Oct 6, 2014
SYMBICORT Astrazeneca budesonide; formoterol fumarate dihydrate 5,674,860 Oct 7, 2014
SUPRANE Baxter Hlthcare desflurane 5,617,906*PED Oct 8, 2014
CHIROCAINE Purdue Pharma Lp levobupivacaine hydrochloride 5,708,011 Oct 13, 2014
COARTEM Novartis artemether; lumefantrine 5,677,331 Oct 14, 2014
CLIMARA PRO Bayer Hlthcare estradiol; levonorgestrel 5,676,968 Oct 14, 2014
VARITHENA Provensis polidocanol RE38919 Oct 14, 2014
ATROVENT HFA Boehringer Ingelheim ipratropium bromide 5,676,930 Oct 14, 2014
VARITHENA Provensis polidocanol RE40640 Oct 14, 2014
TYVASO United Therap treprostinil 5,153,222 Oct 16, 2014
ORENITRAM United Therap treprostinil diolamine 5,153,222 Oct 16, 2014
TOBI Novartis Pharms tobramycin 5,508,269 Oct 19, 2014
BACTROBAN Glaxosmithkline mupirocin calcium 6,025,389 Oct 20, 2014
AUBAGIO Sanofi Aventis Us teriflunomide 5,679,709 Oct 21, 2014
CYCLOSET Veroscience bromocriptine mesylate 5,679,685 Oct 21, 2014
IMODIUM MULTI-SYMPTOM RELIEF Mcneil loperamide hydrochloride; simethicone 5,679,376 Oct 21, 2014
PRAVIGARD PAC (COPACKAGED) Bristol Myers Squibb aspirin; pravastatin sodium 5,622,985*PED Oct 22, 2014
PRAVACHOL Bristol Myers Squibb pravastatin sodium 5,622,985*PED Oct 22, 2014
VELCADE Millennium Pharms bortezomib 6,083,903 Oct 28, 2014
VELCADE Millennium Pharms bortezomib 7,119,080 Oct 28, 2014
VELCADE Millennium Pharms bortezomib 6,617,317 Oct 28, 2014
IPLEX Insmed mecasermin rinfabate recombinant 5,681,818 Oct 28, 2014
VELCADE Millennium Pharms bortezomib 6,297,217 Oct 28, 2014
RYTHMOL SR Glaxosmithkline Llc propafenone hydrochloride 5,681,588 Oct 28, 2014
VELCADE Millennium Pharms bortezomib 6,747,150 Oct 28, 2014
WELCHOL Daiichi Sankyo colesevelam hydrochloride 7,101,960*PED Oct 29, 2014
WELCHOL Daiichi Sankyo colesevelam hydrochloride 6,066,678*PED Oct 29, 2014
WELCHOL Daiichi Sankyo colesevelam hydrochloride 5,679,717*PED Oct 29, 2014
WELCHOL Daiichi Sankyo colesevelam hydrochloride 6,784,254*PED Oct 29, 2014
WELCHOL Daiichi Sankyo colesevelam hydrochloride 5,919,832*PED Oct 29, 2014
WELCHOL Daiichi Sankyo colesevelam hydrochloride 6,433,026*PED Oct 29, 2014
WELCHOL Daiichi Sankyo colesevelam hydrochloride 5,917,007*PED Oct 29, 2014
*Drugs may be covered by multiple patents or regulatory protections. See the DrugPatentWatch database for complete details.

Subscribers have access to valuable datasets, including:

  • Clinical trial information
  • International patent families
  • International patent priority and PCT information
  • Patent maintenance
  • Full-text patent downloads
  • Sales data (top 200 drugs)
  • Paragraph IV challenges
  • Tentative approvals
  • Dynamic search capabilities with data export
  • More…
See the Database Preview and Plan Comparison.

Contact Us with any questions.
Click here for reuse options!
Copyright 2014 Biotechblog

Comments are closed.

%d bloggers like this: